sulfadoxine has been researched along with Day Blindness in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Binquet, C; Denis, P; Fleury, J; Garweg, JG; Kodjikian, L; Peyron, F; Wallon, M | 1 |
Leimer, R; Stemberger, H; Wiedermann, G | 1 |
1 trial(s) available for sulfadoxine and Day Blindness
Article | Year |
---|---|
Tolerability of long-term prophylaxis with fansidar: a randomized double-blind study in Nigeria.
Topics: Adolescent; Adult; Antimalarials; Blood Cell Count; Chloroquine; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Drug Eruptions; Female; Gastrointestinal Diseases; Humans; Liver; Malaria; Male; Middle Aged; Nigeria; Pyrimethamine; Sulfadoxine; Sulfanilamides; Time Factors; Vision Disorders | 1984 |
1 other study(ies) available for sulfadoxine and Day Blindness
Article | Year |
---|---|
Ocular manifestations in congenital toxoplasmosis.
Topics: Adolescent; Adult; Antibodies, Protozoan; Antiprotozoal Agents; Child; Child, Preschool; Chorioretinitis; Drug Combinations; Female; Follow-Up Studies; Humans; Infant; Male; Pyrimethamine; Sulfadoxine; Toxoplasmosis, Congenital; Toxoplasmosis, Ocular; Vision Disorders | 2006 |